Pyxis Oncology (PYXS) Assets Average (2021 - 2025)
Pyxis Oncology (PYXS) has 5 years of Assets Average data on record, last reported at $98.6 million in Q4 2025.
- On a quarterly basis, Assets Average fell 44.08% to $98.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $98.6 million, a 44.08% decrease, with the full-year FY2025 number at $124.4 million, down 24.84% from a year prior.
- Assets Average reached $98.6 million in Q4 2025 per PYXS's latest filing, down from $114.4 million in the prior quarter.
- Over the last five years, Assets Average for PYXS hit a ceiling of $266.4 million in Q1 2022 and a floor of $98.6 million in Q4 2025.
- A 5-year average of $187.7 million and a median of $197.0 million in 2024 define the central range for Assets Average.
- Peak YoY movement for Assets Average: increased 19.71% in 2024, then tumbled 44.08% in 2025.
- Tracing PYXS's Assets Average over 5 years: stood at $209.8 million in 2021, then grew by 3.76% to $217.6 million in 2022, then decreased by 17.2% to $180.2 million in 2023, then decreased by 2.2% to $176.2 million in 2024, then crashed by 44.08% to $98.6 million in 2025.
- Business Quant data shows Assets Average for PYXS at $98.6 million in Q4 2025, $114.4 million in Q3 2025, and $129.5 million in Q2 2025.